BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

352 related articles for article (PubMed ID: 26462035)

  • 1. Inhibitor of apoptosis proteins as intracellular signaling intermediates.
    Kocab AJ; Duckett CS
    FEBS J; 2016 Jan; 283(2):221-31. PubMed ID: 26462035
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A small molecule Smac-mimic compound induces apoptosis and sensitizes TRAIL- and etoposide-induced apoptosis in breast cancer cells.
    Bockbrader KM; Tan M; Sun Y
    Oncogene; 2005 Nov; 24(49):7381-8. PubMed ID: 16044155
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neutralization of Smac/Diablo by inhibitors of apoptosis (IAPs). A caspase-independent mechanism for apoptotic inhibition.
    Wilkinson JC; Wilkinson AS; Scott FL; Csomos RA; Salvesen GS; Duckett CS
    J Biol Chem; 2004 Dec; 279(49):51082-90. PubMed ID: 15371416
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IAP antagonists target cIAP1 to induce TNFalpha-dependent apoptosis.
    Vince JE; Wong WW; Khan N; Feltham R; Chau D; Ahmed AU; Benetatos CA; Chunduru SK; Condon SM; McKinlay M; Brink R; Leverkus M; Tergaonkar V; Schneider P; Callus BA; Koentgen F; Vaux DL; Silke J
    Cell; 2007 Nov; 131(4):682-93. PubMed ID: 18022363
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of Potent SMAC Mimetics that Sensitize Cancer Cells to TNF Family-Induced Apoptosis.
    Welsh K; Milutinovic S; Ardecky RJ; Gonzalez-Lopez M; Ganji SR; Teriete P; Finlay D; Riedl S; Matsuzawa S; Pinilla C; Houghten R; Vuori K; Reed JC; Cosford ND
    PLoS One; 2016; 11(9):e0161952. PubMed ID: 27617834
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The ubiquitin ligase ability of IAPs regulates apoptosis.
    Ni T; Li W; Zou F
    IUBMB Life; 2005 Dec; 57(12):779-85. PubMed ID: 16393780
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design, synthesis, and biological activity of a potent Smac mimetic that sensitizes cancer cells to apoptosis by antagonizing IAPs.
    Zobel K; Wang L; Varfolomeev E; Franklin MC; Elliott LO; Wallweber HJ; Okawa DC; Flygare JA; Vucic D; Fairbrother WJ; Deshayes K
    ACS Chem Biol; 2006 Sep; 1(8):525-33. PubMed ID: 17168540
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combinatorial cancer immunotherapy strategies with proapoptotic small-molecule IAP antagonists.
    Beug ST; Conrad DP; Alain T; Korneluk RG; Lacasse EC
    Int J Dev Biol; 2015; 59(1-3):141-7. PubMed ID: 26374535
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design of small-molecule Smac mimetics as IAP antagonists.
    Wang S
    Curr Top Microbiol Immunol; 2011; 348():89-113. PubMed ID: 21072626
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A small molecule Smac mimic potentiates TRAIL- and TNFalpha-mediated cell death.
    Li L; Thomas RM; Suzuki H; De Brabander JK; Wang X; Harran PG
    Science; 2004 Sep; 305(5689):1471-4. PubMed ID: 15353805
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mathematical modeling of the regulation of caspase-3 activation and degradation.
    Stucki JW; Simon HU
    J Theor Biol; 2005 May; 234(1):123-31. PubMed ID: 15721041
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SMAC-expression in denervated human skeletal muscle as a potential inhibitor of coexpressed inhibitor-of-apoptosis proteins.
    Tews DS; Behrhof W; Schindler S
    Appl Immunohistochem Mol Morphol; 2008 Jan; 16(1):66-70. PubMed ID: 18091317
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structure-based design and molecular profiling of Smac-mimetics selective for cellular IAPs.
    Corti A; Milani M; Lecis D; Seneci P; de Rosa M; Mastrangelo E; Cossu F
    FEBS J; 2018 Sep; 285(17):3286-3298. PubMed ID: 30055105
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhanced cytoprotective effects of the inhibitor of apoptosis protein cellular IAP1 through stabilization with TRAF2.
    Csomos RA; Brady GF; Duckett CS
    J Biol Chem; 2009 Jul; 284(31):20531-9. PubMed ID: 19506082
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Smac mimetic Birinapant induces apoptosis and enhances TRAIL potency in inflammatory breast cancer cells in an IAP-dependent and TNF-α-independent mechanism.
    Allensworth JL; Sauer SJ; Lyerly HK; Morse MA; Devi GR
    Breast Cancer Res Treat; 2013 Jan; 137(2):359-71. PubMed ID: 23225169
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Roles of c-IAP proteins in TNF receptor family activation of NF-κB signaling.
    Varfolomeev E; Goncharov T; Vucic D
    Methods Mol Biol; 2015; 1280():269-82. PubMed ID: 25736754
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IAP family of cell death and signaling regulators.
    Silke J; Vucic D
    Methods Enzymol; 2014; 545():35-65. PubMed ID: 25065885
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bivalent SMAC Mimetics for Treating Cancer by Antagonizing Inhibitor of Apoptosis Proteins.
    Zhu H; Li Y; Liu Y; Han B
    ChemMedChem; 2019 Dec; 14(23):1951-1962. PubMed ID: 31692274
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential role of RIP1 in Smac mimetic-mediated chemosensitization of neuroblastoma cells.
    Czaplinski S; Abhari BA; Torkov A; Seggewiß D; Hugle M; Fulda S
    Oncotarget; 2015 Dec; 6(39):41522-34. PubMed ID: 26575016
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Multiple Roles of the IAP Super-family in cancer.
    Kumar S; Fairmichael C; Longley DB; Turkington RC
    Pharmacol Ther; 2020 Oct; 214():107610. PubMed ID: 32585232
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.